MT-2 Chemical Structure & Synthesis | Palmetto Peptides

Chemical Structure and Synthesis of Melanotan II (MT-2) Research Peptide Explained

Research Notice: This article covers research on Melanotan II (MT-2) research peptide and PT-141 research peptide — available from Palmetto Peptides for laboratory use only.

Research Use Only Disclaimer: MT-2 (Melanotan II) is sold strictly for in vitro and laboratory research purposes. It is not approved by the FDA for human or veterinary use. All content on this page is intended for licensed researchers and scientific education only.

For background on this topic, see the Complete Guide to MT-2 (Melanotan II) Research Peptide from Palmetto Peptides.

Last Updated: April 19, 2026 | Reading Time: Approximately 9 minutes | Author: Palmetto Peptides Research Team

Quick Answer

MT-2 (Melanotan II) is a synthetic cyclic heptapeptide with the sequence Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂. That shorthand packs a significant amount of structural information, and unpacking it reveals exactly why MT-2 behaves the way it does in melanocortin receptor binding assays.

What Is the Chemical Structure of MT-2 Research Peptide?

MT-2 (Melanotan II) is a synthetic cyclic heptapeptide with the sequence Ac-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂. That shorthand packs a significant amount of structural information, and unpacking it reveals exactly why MT-2 behaves the way it does in melanocortin receptor binding assays. Its cyclic backbone, non-natural amino acid substitutions, and terminal modifications work together to give this peptide both stability and potency that the native hormone alpha-melanocyte-stimulating hormone (α-MSH) simply cannot match in a laboratory setting.

The Full Amino Acid Sequence and What It Means

MT-2 is derived from the core active sequence of α-MSH — specifically the "message" region responsible for receptor activation. The native α-MSH sequence (His-Phe-Arg-Trp at positions 6–9) is often called the pharmacophore, and MT-2 preserves and optimizes this core while stripping away the flanking residues that contribute to rapid enzymatic degradation.

MT-2 Sequence Breakdown

N-terminus

Acetyl group (Ac)

Cap that resists aminopeptidase cleavage

1

Nle (Norleucine)

Non-natural isostere of Met; oxidation-resistant replacement

2

Asp (Aspartic acid)

Part of lactam bridge; negatively charged side chain

3

His (Histidine)

Conserved from α-MSH pharmacophore

4

D-Phe (D-Phenylalanine)

Non-natural D-amino acid; enhances receptor potency

5

Arg (Arginine)

6

Trp (Tryptophan)

7

Lys (Lysine)

Part of lactam bridge; positively charged side chain

C-terminus

Amide (-NH₂)

Cap that resists carboxypeptidase cleavage

The lactam bridge connects the side chains of Asp (position 2) and Lys (position 7), forming the cyclic backbone that defines MT-2's three-dimensional shape.

The Cyclic Lactam Structure: Why It Matters in Research

Most researchers who work with MT-2 are aware it is "cyclic," but it is worth understanding what that means structurally and why it has practical implications for lab work.

What Is a Lactam Bridge?

A lactam is a cyclic amide formed by a condensation reaction between a carboxylic acid and an amine group. In MT-2, this bridge forms between:

The side-chain carboxyl group of Aspartic acid (position 2)

The side-chain amine group of Lysine (position 7)

The result is a covalent ring that locks the peptide into a specific three-dimensional conformation. Unlike a linear peptide, which can rotate freely around most backbone bonds, MT-2's cyclic structure is constrained.

Research Implications of Cyclic Conformation

Why this matters in receptor studies:

A conformationally constrained peptide presents a fixed shape to a receptor binding site. This has two important effects:

Increased receptor binding affinity — The peptide's shape can be pre-organized to match the receptor's binding pocket, reducing the entropic cost of binding. MT-2 binds melanocortin receptors with higher affinity than linear α-MSH analogs.

Increased metabolic stability — Cyclic peptides are significantly more resistant to proteolytic degradation than linear peptides. The lactam bridge physically prevents certain proteases from accessing and cleaving the backbone, which is why MT-2 is more stable in aqueous solution than α-MSH.

Key Non-Natural Amino Acid Substitutions

Two deliberate substitutions distinguish MT-2's sequence from anything that occurs naturally in biology:

1. Norleucine (Nle) Replacing Methionine (Met)

In the native α-MSH sequence, position 4 contains Methionine. Methionine contains a thioether side chain that is susceptible to oxidation — a serious problem for long-term stability in research applications. Norleucine is a structural isostere of Methionine: same carbon chain length, but with a simple methylene group instead of a thioether. This substitution eliminates the oxidation liability while preserving the steric properties that contribute to receptor interactions.

2. D-Phenylalanine (D-Phe) Replacing L-Phenylalanine (L-Phe)

This substitution is arguably the most pharmacologically significant structural feature of MT-2. D-amino acids are the mirror image of the naturally occurring L-amino acids. Replacing L-Phe with D-Phe at position 7 of the active sequence causes the peptide backbone to fold in a way that positions the pharmacophore — the His-D-Phe-Arg-Trp sequence — in an optimal orientation for melanocortin receptor engagement.

This is not a subtle effect. D-Phe incorporation is the primary reason MT-2 is orders of magnitude more potent than native α-MSH in in vitro receptor binding assays.

Molecular Formula and Physical Properties

Molecular Formula: C₅₀H₆₉N₁₅O₉

Molecular Weight: 1024.18 g/mol

CAS Number: 121062-08-6

Appearance: White to off-white lyophilized powder

Solubility: Soluble in water and acetic acid (0.1% AA commonly used in research reconstitution protocols)

Researchers looking for a broader overview of this compound can refer to the Complete Guide to MT-2 (Melanotan II) Research Peptide, which covers the full research landscape in detail.

Storage: Best maintained lyophilized at -20°C or lower; protect from light and moisture

Synthesis Methodology: How MT-2 Is Produced in Research-Grade Form

MT-2 is synthesized using Solid-Phase Peptide Synthesis (SPPS), the standard methodology for producing synthetic peptides at research scale. SPPS was pioneered by Robert Bruce Merrifield (Nobel Prize in Chemistry, 1984) and has been refined into highly efficient protocols capable of producing peptides with high purity and yield.

The SPPS Process (Simplified for Clarity)

Think of SPPS like building a chain one link at a time, where each link is an amino acid. Instead of working in solution (which is messy and hard to purify at each step), SPPS attaches the growing chain to an insoluble resin bead. Unreacted materials are simply washed away at each step.

The general sequence:

Resin loading — The C-terminal amino acid (Lys in MT-2's case) is attached to a solid resin support via its carboxyl group.

Deprotection — The protecting group on the amine of the attached amino acid is removed to allow the next coupling.

Coupling — The next protected amino acid is added and chemically activated to form a peptide bond with the growing chain.

Repeat — Steps 2–3 repeat for each amino acid in sequence (working from C-terminus to N-terminus).

Cleavage — The completed linear peptide is cleaved from the resin.

Cyclization — The lactam bridge between Asp and Lys side chains is formed through a selective condensation reaction. This is a critical step that requires careful protection strategy to avoid unwanted side reactions.

N-terminal acetylation and C-terminal amidation — Terminal modifications are incorporated either during SPPS (amide resins provide C-terminal amides automatically) or as post-assembly steps.

Purification — The crude peptide is purified by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC).

Analysis — Purity is confirmed by analytical RP-HPLC and identity is confirmed by Mass Spectrometry (MS).

Lyophilization — The purified peptide solution is freeze-dried to produce a stable powder.

Why Cyclization Is the Most Challenging Step

Forming the Asp-Lys lactam selectively while the rest of the peptide is intact requires careful orthogonal protection strategies. If multiple reactive side chains are unprotected simultaneously, unwanted bridging can occur. Research-grade MT-2 suppliers use validated protocols with specific protecting group combinations (typically Fmoc SPPS with selective Asp/Lys deprotection prior to lactam formation) to ensure that only the intended bridge forms.

Purity Standards for Research-Grade MT-2

For MT-2 to be useful as a reference compound in receptor studies, it must meet defined purity thresholds. Research-grade MT-2 should be characterized by:

Purity by HPLC: ≥98% (some suppliers specify ≥99%)

Identity by MS: Molecular ion peak consistent with C₅₀H₆₉N₁₅O₉ (MW 1024.18)

Endotoxin testing: Especially important for any in vitro cell culture work; endotoxin contamination can confound experimental results

Appearance: Consistent white/off-white lyophilized powder

Researchers should request and review Certificates of Analysis (CoA) from suppliers confirming these parameters. See our Purity Testing and Quality Control Methods for MT-2 Research Peptides article for detailed guidance on evaluating supplier CoAs.

Structural Comparison: MT-2 vs. Native α-MSH

Length

13 amino acids

7 amino acids

Conformation

Linear

Cyclic (lactam bridge)

Met at position 4

Yes (oxidation-susceptible)

Replaced by Nle

Phe stereochemistry

L-Phe

D-Phe (inverted)

Terminal modifications

None

N-Ac / C-amide

Metabolic stability

Low

High

Receptor selectivity

Primarily MC1R

MC1R, MC3R, MC4R, MC5R

Related Research Articles

The Palmetto Peptides Complete Guide to the Research Peptide MT-2 (Melanotan II) — Pillar Page

History and Development of MT-2 Research Peptide: From Discovery to Modern Laboratory Use

Mechanism of Action of MT-2 Research Peptide in Melanocortin Receptor Studies

Purity Testing and Quality Control Methods for MT-2 Research Peptides

Step-by-Step Reconstitution of MT-2 Research Peptide for Laboratory Experiments

Long-Term Stability of Reconstituted MT-2 Research Peptide Solutions for Lab Protocols

Frequently Asked Questions

Q: What is the molecular weight of MT-2?

MT-2 (Melanotan II) has a molecular weight of approximately 1024.18 g/mol with the molecular formula C₅₀H₆₉N₁₅O₉.

Q: Why does MT-2 contain D-Phenylalanine instead of L-Phenylalanine?

The D-Phe substitution at position 4 of the pharmacophore sequence causes the peptide to adopt a conformation that is highly complementary to melanocortin receptor binding sites, dramatically increasing potency compared to linear analogs with natural L-amino acids.

Q: What does "cyclic" mean in the context of MT-2's structure?

MT-2 is cyclic because a covalent lactam bridge connects the side chains of its Aspartate and Lysine residues, forming a ring structure that locks the peptide into a defined three-dimensional shape. This improves both receptor binding affinity and resistance to enzymatic degradation.

Q: How is research-grade MT-2 synthesized?

MT-2 is produced using solid-phase peptide synthesis (SPPS), followed by cyclization to form the lactam bridge, purification by RP-HPLC, and lyophilization. Identity and purity are confirmed by mass spectrometry and analytical HPLC.

Q: What purity level should research-grade MT-2 have?

For reliable in vitro research, MT-2 should have ≥98% purity as confirmed by HPLC, with identity verified by mass spectrometry. Researchers should always review a Certificate of Analysis from the supplier.

Peer-Reviewed Citations

Hruby, V.J., et al. (1987). Cyclic lactam analogs of α-melanotropin with high potency and selectivity. *Journal of Medicinal Chemistry*, 30(6), 1094–1098.

Al-Obeidi, F., et al. (1989). Design of a new class of superpotent cyclic alpha-melanotropins based on quenched dynamic simulations. *Journal of the American Chemical Society*, 111(9), 3413–3416.

Merrifield, R.B. (1963). Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. *Journal of the American Chemical Society*, 85(14), 2149–2154.

Grieco, P., et al. (2000). Synthesis and biological evaluation of novel alpha-MSH analogs modified in the His6-Phe7 positions. *Journal of Medicinal Chemistry*, 43(25), 4998–5002.

Toth, I., & Hussain, A. (Eds.). (2020). *Peptide Chemistry and Drug Design*. Wiley.

Palmetto Peptides Research Team

All products are sold for research and laboratory use only. Not for human or veterinary use. These statements have not been evaluated by the Food and Drug Administration.

Related research: MT-2 melanocortin receptor mechanism, and MT-2 laboratory research applications.

See Also: Complete MT-2 Melanotan II Research Guide

Related Research

Buyer's Guide: What to Consider When Purchasing MT-2 Research Peptide Online